Xavier Tekpli

11PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 14, 2026
Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes.

Lilly Anne Torland, Jürgen Geisler, Youness Azimzade

|Jun 16, 2025
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

Andreas Hagen Røssevold, Xavier Tekpli, Ole Christian Lingjærde

|Jun 26, 2024
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition.

Leonard Schmiester, Fara Brasó-Maristany, Blanca González-Farré

|Aug 18, 2022
Subtype and cell type specific expression of lncRNAs provide insight into breast cancer.

Sunniva Stordal Bjørklund, Miriam Ragle Aure, Jari Häkkinen

|Mar 30, 2022
Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer.

Jørgen Ankill, Miriam Ragle Aure, Sunniva Bjørklund

|Apr 30, 2021
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.

Miriam Ragle Aure, Thomas Fleischer, Sunniva Bjørklund

Pageof 2